LGC Group Acquires Kova International from One Rock Capital Partners
July 24, 2023
LGC Group has acquired Kova International, Inc., a Garden Grove, California-based developer and manufacturer of in vitro diagnostic controls, from an affiliate of One Rock Capital Partners. Kova operates urinalysis and toxicology controls product lines; financial terms were not disclosed and Baird served as financial advisor to Kova.
- Buyers
- LGC Group, LGC Clinical Diagnostics
- Targets
- KOVA International, Inc.
- Sellers
- One Rock Capital Partners, LLC (affiliate)
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Astorg and Cinven Acquire LGC
November 21, 2019
Healthcare Services
A consortium led by private equity firms Astorg and Cinven has signed an agreement to acquire LGC, a UK-headquartered global leader in life sciences tools. The buyout will back LGC’s continued organic growth and M&A-led expansion across its standards, genomics and laboratory services businesses; financial terms were not disclosed and the transaction remains subject to regulatory approvals.
-
Industrial Inspection & Analysis Acquires Kova Engineering Ltd.
December 9, 2024
Industrial Services
Industrial Inspection & Analysis (IIA) has acquired Canada-based Kova Engineering Ltd., adding Kova’s lift inspection, NDT and certification capabilities and 15 Canadian offices to IIA’s footprint. The deal makes IIA the largest third-party lift inspection provider in North America and expands its engineering and inspection capabilities across multiple industries.
-
WCG Acquires The Avoca Group
May 11, 2021
Healthcare Services
WCG, a provider of clinical trial solutions, has acquired The Avoca Group, a life sciences consulting firm focused on clinical trial quality management, benchmarking and analytics. The acquisition strengthens WCG's capabilities in quality management, benchmarking and compliance to accelerate clinical research and improve trial efficiency.
-
Curative Inc. Acquires KorvaLabs, Inc.
May 19, 2020
Healthcare Services
Curative Inc. has acquired KorvaLabs, a CLIA-certified and DEA-licensed analytical laboratory based in San Dimas, California, formalizing a partnership that supported Curative's manufacture and processing of its oral fluid COVID-19 test. The acquisition strengthens Curative's testing capacity — to date the organizations processed 245,371 tests together and were processing roughly 14,000 tests per day — and secures in-house manufacturing and processing capabilities.
-
Graham Partners Growth Invests in Kinova Group Inc.
December 14, 2021
Manufacturing
Graham Partners Growth, the growth equity strategy of Graham Partners, has completed a minority growth equity investment in Kinova Group Inc., a Boisbriand, Quebec–based designer and manufacturer of collaborative robotic arms (cobots). The investment will provide growth capital and operational support as Kinova expands its presence across medical, assistive and industrial automation end markets.
-
Alliance Pharma (Ampersand-backed) Acquires LGC's Drug Development Solutions; KKR Joins as Equal Shareholder
May 17, 2022
Healthcare Services
Alliance Pharma, an Ampersand-backed US bioanalytical CRO, acquired Drug Development Solutions (DDS), LGC’s UK-based bioanalytical and materials science testing business. Ampersand Capital Partners and KKR will be equal shareholders in the combined business to expand geographic reach, broaden laboratory capabilities, and extend the service portfolio internationally.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.